Dear Editor:
Hydroa vacciniforme (HV)-like lymphoproliferative disease (LPD) is associated with chronic active Epstein-Barr virus (CAEBV) infection. It ranges from classic and severe/systemic HV to HV-like lymphoma (HVLL)1. Cutaneous manifestations include vesiculopapules, bullae, ulcers, and facial swelling1. HVLL usually has a long clinical course with spontaneous resolution1 but may progress to more severe and life-threatening conditions2. We report a rare case of HV-like LPD that evolved from classic HV to orogenital ulcerations.
A 17-year-old Chinese boy presented with a 2-month history of painful orogenital swelling and ulcerative lesions without constitutional symptoms. He was diagnosed with classic HV at age 2 years, based on the typical papulovesicular eruptions on his face and photosensitivity. The symptoms spontaneously resolved 2 years before without recurrence, leaving facial varioliform scars (Fig. 1A). Physical examination revealed marked swelling on the lower lip and massive erosions with ulcerations on the scrotum (Fig. 1A, B). No lymphadenopathy was observed. A skin biopsy from the lower lip showed diffuse infiltrates of atypical lymphoid cells throughout the dermis, with remarkable epidermotropism (Fig. 2A). Immunohistochemical analysis revealed CD3+++, CD4+++, Granzyme B++, and TIA1+++ infiltrating lymphocytes, consistent with an activated cytotoxic T-cell phenotype (Fig. 2B~D). In situ hybridization for EBV-encoded small RNA (EBER) revealed diffuse positivity (Fig. 2E). T-cell receptor gene gamma rear-rangement indicated clonality. Peripheral blood flow cytometry demonstrated normal amounts of CD3+/CD4+ T cells and CD3+CD8+ T cells. The EBV DNA viral load in peripheral lymphocytes was elevated (1.69×106 copies/ml; normal range, 0~5,000 copies/ml). Titers of IgG antibodies to the EBV capsid antigen and EBV nuclear antigen-1 were high. These findings confirmed the diagnosis of HV-like LPD. The patient was then treated with interferon alpha-2b 300 IU 3 times per week based on previous reports but showed no significant improvement2. As his orogenital swelling and ulcerations worsened, human leukocyte antigen-haploidentical donor lymphocyte infusion was administered3. A total of 4.8×109 peripheral blood mononuclear cells (about 1×108/kg) was infused. The lesions gradually resolved and remained stable thereafter.
Fig. 1. We received the patient’s consent form about publishing all photographic materials. (A) Lower lip swelling with scales and varioliform scars on the face. (B) Remarkable erosions and ulcerations on the scrotum.
Fig. 2. (A) Histopathology shows diffuse infiltrate of atypical lymphoid cells in the dermis, with marked epidermotropism (H&E, left: magnification ×50, right: magnification ×200). (B~D) Immunostaining reveals that the infiltrating lymphocytes were positive for CD4, Granzyme B, and TIA-1 (left: magnification ×50; right: magnification ×200). (E) In situ hybridization showed strong EBV-encoded small RNA (EBER) positivity throughout the infiltrating lymphocytes (left: magnification ×50; right: magnification ×200).
HV-like LPD is a chronic EBV-positive lymphoproliferative disorder with a broad spectrum of clinical aggressive1,2. Classic HV is a benign photodermatosis characterized by cursted papulovesicles and varicelliform scars after healing1, as in our patient in childhood. As the disease progresses, more extensive skin lesions develop1, such as blisters, ulcers, exaggerated arthropod bite reactions, and edema4. Oculomucosal and gastrointestinal involvement are sometimes complicated5. Overt systemic lymphoma may occur and lead to poor prognosis1,4. No standard treatment has been established. A conservative approach is recommended for indolent cases, whereas hematopoietic stem cell transplantation might benefit patients with advanced cases1,2.
Our patient presented with ulcerative lesions solely on the orogenital area after 2 years of HV remission, which has not been described in previous cases of HV-like LPD. The presence of clonal T cells indicated the possibility of progression to lymphoma2. Conservative treatment was ineffective for disease control. This case highlights the importance of recognizing the uncommon clinical features of CAEBV. It shows that classic HV may progress even after years of remission of the initial manifestations.
ACKNOWLEDGMENT
The authors thank the staff of Department of Hematology at Peking University First Hospital for providing treatment information.
Footnotes
CONFLICTS OF INTEREST: The authors have nothing to disclose.
FUNDING SOURCE: None.
References
- 1.Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th revised ed. Lyon: International Agency for Research on Cancer; 2017. pp. 355–362. [Google Scholar]
- 2.Quintanilla-Martinez L, Ridaura C, Nagl F, Sáez-de-Ocariz M, Durán-McKinster C, Ruiz-Maldonado R, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122:3101–3110. doi: 10.1182/blood-2013-05-502203. [DOI] [PubMed] [Google Scholar]
- 3.Wang Q, Liu H, Zhang X, Liu Q, Xing Y, Zhou X, et al. High doses of mother’s lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood. Blood. 2010;116:5941–5947. doi: 10.1182/blood-2010-01-262311. [DOI] [PubMed] [Google Scholar]
- 4.Sangueza M, Plaza JA. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases. J Am Acad Dermatol. 2013;69:112–119. doi: 10.1016/j.jaad.2013.01.037. [DOI] [PubMed] [Google Scholar]
- 5.Yamamoto T, Hirai Y, Miyake T, Yamasaki O, Morizane S, Iwatsuki K. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme. Eur J Dermatol. 2012;22:380–383. doi: 10.1684/ejd.2012.1665. [DOI] [PubMed] [Google Scholar]


